Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 2/20 | 0.32 |
| ▸ | INMT | O95050 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5111613 | 0.98 | ALDH1A1 (0.35) | MAPTALDH1A1PSMB1PSMB5USP2 | |
| SCHEMBL6699994 | 0.98 | ALDH1A1 (0.35) | MAPTALDH1A1PSMB1PSMB5USP2 | |
| SCHEMBL14818806 | 0.98 | ALDH1A1 (0.35) | MAPTALDH1A1PSMB1PSMB5USP2 | |
| SCHEMBL23661069 | 0.98 | ALDH1A1 (0.35) | MAPTALDH1A1PSMB1PSMB5USP2 | |
| SCHEMBL8992014 | 0.98 | ALDH1A1 (0.35) | MAPTALDH1A1PSMB1PSMB5USP2 | |
| SCHEMBL23486255 | 0.98 | ALDH1A1 (0.35) | MAPTALDH1A1PSMB1PSMB5USP2 | |
| SCHEMBL8420655 | 0.98 | ALDH1A1 (0.35) | MAPTALDH1A1PSMB1PSMB5USP2 | |
| SCHEMBL497507 | 0.98 | ALDH1A1 (0.35) | MAPTALDH1A1PSMB1PSMB5USP2 | |
| SCHEMBL11110396 | 0.98 | ALDH1A1 (0.35) | MAPTALDH1A1PSMB1PSMB5USP2 | |
| SCHEMBL8992009 | 0.98 | ALDH1A1 (0.35) | MAPTALDH1A1PSMB1PSMB5USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 518 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509598-B2 | Process solution composition for polymer treatment comprising a fluorine compound, a ketone solvent, and a polar aprotic solvent | DONGWOO FINE-CHEM CO., LTD. (KR) | 2025-12-30 | — | — | US | claimed |
| EP-4479487-A1 | SOLUBLE WATER SCAVENGER MOLECULES FOR USE WITH DIELECTRIC FLUIDS | General Electric Technology GmbH (CH) | 2024-12-25 | — | — | EP | claimed |
| CN-118165259-A | Waterborne polyurethane, preparation method thereof, expansion type steel structure fireproof coating containing waterborne polyurethane and transparent facing type fireproof coating | 山西省建筑科学研究院集团有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-118165251-A | Nonionic type double-amino hydrophilic chain extender and preparation method thereof, and nonionic type water-based non-isocyanate polyurethane and preparation method thereof | 山西省建筑科学研究院集团有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-118165260-A | Waterborne polyurethane, preparation method thereof, expansion type steel structure fireproof coating containing waterborne polyurethane and transparent facing type fireproof coating | 山西省建筑科学研究院集团有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-117417245-A | Method for synthesizing ketoprofen through pyrolytic aromatization reaction | 复旦大学 | 2024-01-19 | — | — | CN | claimed |
| WO-2023156969-A1 | SOLUBLE WATER SCAVENGER MOLECULES FOR USE WITH DIELECTRIC FLUIDS | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2023-08-24 | — | — | WO | claimed |
| US-20230265349-A1 | SOLUBLE WATER SCAVENGER MOLECULES FOR USE WITH DIELECTRIC FLUIDS | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2023-08-24 | — | — | US | claimed |
| US-20220119569-A1 | Curable and Solvent Soluble Formulations and Methods of Making and Using Therof | POLY6 TECHNOLOGIES, INC. | 2022-04-21 | — | — | US | claimed |
| CN-112586583-A | Low-fat low-sugar high-protein chocolate product and preparation method thereof | 安徽兆龙食品有限公司 | 2021-04-02 | — | — | CN | claimed |
| WO-2004078708-A2 | NOVEL METHOD FOR SYNTHESISING DERIVATIVES OF (2S, 3AS, 7AS)-1-[(S)-ALANYL]-OCTAHYDRO,-IH-INDOLE-2-CARBOXYLIC ACID AND THE USE THEREOF FOR PERINDOPRIL SYNTHESIS | LES LABORATOIRES SERVIER (FR) | 2004-09-16 | — | — | WO | claimed |
| WO-2004078707-A2 | NOVEL METHOD FOR SYNTHESISING (2S, 3AS, 7AS)-PERHYDROINDOLE-2-CARBOXYLIC ACID AND THE ESTERS THEREOF AND THE USE THEREOF FOR PERINDOPRIL SYNTHESIS | LES LABORATOIRES SERVIER (FR) | 2004-09-16 | — | — | WO | claimed |
| WO-2004078107-A2 | NOVEL METHOD FOR SYNTHESISING PERINDOPRIL AND THE PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | LES LABORATOIRES SERVIER (FR) | 2004-09-16 | — | — | WO | claimed |
| EP-1455736-A1 | RESTRUCTURING AND FINISHING OF KERATIN FIBERS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-09-15 | — | — | EP | claimed |
| EP-1403275-A1 | Process for the synthesis of perindopril and its pharmaceutically acceptable salts | Les Laboratoires Servier (FR) | 2004-03-31 | — | — | EP | claimed |
| EP-1403277-A1 | Method for synthesis of (2S,3aS,7aS)-1-((S)-alanyl)-octahydro-1H-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril | LES LABORATOIRES SERVIER (FR) | 2004-03-31 | — | — | EP | claimed |
| EP-1338591-A1 | Method for synthesis of (2S,3aS,7aS)-perhydroindole-2- carboxylic acid and esters thereof, and use in the synthesis of perindopril | Les Laboratoires Servier (FR) | 2003-08-27 | — | — | EP | claimed |
| WO-2003053375-A1 | RESTRUCTURING AND FINISHING OF KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-07-03 | — | — | WO | claimed |
| US-6153783-A | REACTING A CYCLOALKANONE WITH A 2-SUBSTITUTED-1-ALKENE USING AN ENAMINE CATALYST TO PRODUCE A CORRESPONDINGLY SUBSTITUTED INTERMEDIATE; RING OPENING BY ULTRAVIOLET RADIATION AND USING A REACTING SOLVENT | COGNIS CORPORATION (US) | 2000-11-28 | — | — | US | claimed |
| US-6086661-A | (A)IMIDAZOLINIUM QUATERNARY SALT, (B) PHOSPHONIUM QUATERNARY SALT, OR (C) AN AMMONIUM QUATERNARY SALT; A PAPER-CURL REDUCING COMPOUND; DYE; STABILIZERS, BIOCIDE, WATER SOLUBLE SALT | XEROX CORPORATION (US) | 2000-07-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509598-B2 | Process solution composition for polymer treatment comprising a fluorine compound, a ketone solvent, and a polar aprotic solvent | CHRM1, CHRM2, PNMT | MAPT 835/4885ALDH1A1 1453/4885PSMB1 1618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.